4-ANDROSTENEDIOL

C[C@]12CC[C@H]3[C@@H](CCC4=C[C@@H](O)CC[C@]34C)[C@@H]1CC[C@@H]2O

InChIKey=BTTWKVFKBPAFDK-LOVVWNRFSA-N

InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,13-17,20-21H,3-10H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	7 / 7
E/Z Centers	0
Optical Activity	UNSPECIFIED

PubMed

Title	Date	PubMed
		20181066
[Urinary nandrolone metabolites in antidoping control].	2001 Sep	11787429
Oral andro-related prohormone supplementation: do the potential risks outweigh the benefits?	2003 Feb	12671199
Microbial transformation of dehydroepiandrosterone.	2003 Jun	12737407

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:08:22 GMT 2025` Edited by `admin` on `Mon Mar 31 23:08:22 GMT 2025`
Record UNII	G10EHA9I0D
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

4-ANDROSTENEDIOL

Systematic Name

English

NSC-12458

Preferred Name

English

ANDROST-4-ENE-1,1 DIOL

Systematic Name

English

4-ANDENDIOL

Common Name

English

4-ANDROSTENE-3.BETA.O,17.BETA.-DIOL

Systematic Name

English

TESTOSTERONE IMPURITY D [EP IMPURITY]

Common Name

English

ANDROST-4-ENE-3BETA,17BETA-DIOL

Systematic Name

English

ANDROST-4-ENE-3.BETA.,17.BETA.-DIOL

Systematic Name

English

Classification Tree Code System Code

DEA NO.

4000